Dark Forest Capital Management LP Viking Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $3,962 - $5,915	-1,878 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.0 - $4.88 $5,634 - $9,164	1,878 New	1,878 $6,000
Q4 2021 Feb 11, 2022	SELL	$4.6 - $6.72 $12,590 - $18,392	-2,737 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.58 - $7.04 $11,611 - $14,650	2,081 Added 317.23%	2,737 $17,000
Q2 2021 Aug 16, 2021	BUY	$5.19 - $6.73 $3,404 - $4,414	656 New	656 $4,000

442

63.3M

6.23M

2.97M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.83B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.